The zinc finger protein ZNF268 is overexpressed in human cervical cancer and contributes to tumorigenesis via enhancing NF-κB signaling

Journal of Biological Chemistry

Volumn 287, Issue 51, 2012, Pages 42856-42866

  Wang, Wei ^a   Guo, Mingxiong ^a   Hu, Li ^a   Cai, Jinyang ^a   Zeng, Yan ^a   Luo, Jun ^a   Shu, Zhiqiang ^a   Li, Wenxin ^a   Huang, Zan ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CELL-CYCLE ARREST; CERVICAL CANCER CELLS; CERVICAL CANCERS; COLONY FORMATION; HELA CELL; HIGH FREQUENCY; HUMAN PAPILLOMAVIRUS; IN-VITRO; INDUCED APOPTOSIS; ISOFORMS; NUDE MICE; OVER-EXPRESSION; TUMORIGENESIS; WOMEN'S HEALTH; ZINC FINGER PROTEIN;

CELL DEATH; PATHOLOGY; TISSUE; ZINC;

PROTEINS;

CASPASE 3; I KAPPA B KINASE ALPHA; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MEMBRANE PROTEIN; PROTEIN RIP1; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN; ZINC FINGER PROTEIN 268; ZINC FINGER PROTEIN 268B;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME DEGRADATION; FEMALE; G1 PHASE CELL CYCLE CHECKPOINT; GENE FUNCTION; GENE OVEREXPRESSION; GENE SILENCING; HELA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR SIGNALING; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN PHOSPHORYLATION; TUMOR GROWTH; UPREGULATION; UTERINE CERVIX CANCER;

ANIMALS; APOPTOSIS; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CYCLOHEXIMIDE; DOWN-REGULATION; FEMALE; GENE KNOCKDOWN TECHNIQUES; HELA CELLS; HUMANS; I-KAPPA B PROTEINS; IMMUNOHISTOCHEMISTRY; MICE; MICE, NUDE; NF-KAPPA B; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR-ALPHA; UTERINE CERVICAL NEOPLASMS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

HUMAN PAPILLOMAVIRUS; MUS MUSCULUS;

EID: 84871145018     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.399923     Document Type: Article

References (41)

1. Urrutia, R. (2003) KRAB-containing zinc-finger repressor proteins. Genome Biol. 4, 231
2. Gou, D. M., Sun, Y., Gao, L., Chow, L. M., Huang, J., Feng, Y. D., Jiang, D. H., and Li, W. X. (2001) Cloning and characterization of a novel Krüppel-like zinc finger gene, ZNF268, expressed in early human embryo. Biochim. Biophys. Acta 1518, 306-310 (Pubitemid 32324199)
3. Shao, H., Zhu, C., Zhao, Z., Guo, M., Qiu, H., Liu, H., Wang, D., Xue, L., Gao, L., Sun, C., and Li, W. (2006) KRAB-containing zinc finger gene ZNF268 encodes multiple alternatively spliced isoforms that contain transcription regulatory domains. Int. J. Mol. Med. 18, 457-463
4. 2-type zinc finger protein, ZNF268s, regulates NF-κB activation by TNF-α. Mol. Cells 26, 175-180
5. Guo, M. X., Wang, D., Shao, H. J., Qiu, H. L., Xue, L., Zhao, Z. Z., Zhu, C. G., Shi, Y. B., and Li, W. X. (2006) Transcription of human zinc finger ZNF268 gene requires an intragenic promoter element. J. Biol. Chem. 281, 24623-24636 (Pubitemid 44274236)
6. Sun, Y., Shao, H., Li, Z., Liu, J., Gao, L., Peng, X., Meng, Y., and Li, W. (2004) ZNF268, a novel Kruppel-like zinc finger protein, is implicated in early human liver development. Int. J. Mol. Med. 14, 971-975
7. Krackhardt, A. M., Witzens, M., Harig, S., Hodi, F. S., Zauls, A. J., Chessia, M., Barrett, P., and Gribben, J. G. (2002) Identification of tumor-associated antigens in chronic lymphocytic leukemia by SEREX. Blood 100, 2123-2131 (Pubitemid 35001247)
8. Wang, D., Guo, M. X., Hu, H. M., Zhao, Z. Z., Qiu, H. L., Shao, H. J., Zhu, C. G., Xue, L., Shi, Y. B., and Li, W. X. (2008) Human T-cell leukemia virus type 1 oncoprotein tax represses ZNF268 expression through the cAMP-responsive element-binding protein/activating transcription factor pathway. J. Biol. Chem. 283, 16299-16308
9. Zeng, Y., Wang, W., Ma, J., Wang, X., Guo, M., and Li, W. (2012) Knockdown of ZNF268, which is transcriptionally down-regulated by GATA-1, promotes proliferation of K562 cells. PLoS ONE 7, e29518
10. Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., and Forman, D. (2011) Global cancer statistics. CA Cancer J. Clin. 61, 69-90
11. Walboomers, J. M., Jacobs, M. V., Manos, M. M., Bosch, F. X., Kummer, J. A., Shah, K. V., Snijders, P. J., Peto, J., Meijer, C. J., and Muñoz, N. (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 189, 12-19 (Pubitemid 29406813)
12. Magnusson, P. K., Lichtenstein, P., and Gyllensten, U. B. (2000) Heritability of cervical tumours. Int. J. Cancer 88, 698-701
13. Engelmark, M. T., Ivansson, E. L., Magnusson, J. J., Gustavsson, I. M., Beskow, A. H., Magnusson, P. K., and Gyllensten, U. B. (2006) Identification of susceptibility loci for cervical carcinoma by genome scan of affected sib-pairs. Hum. Mol. Genet. 15, 3351-3360 (Pubitemid 44642626)
14. Wilting, S. M., de Wilde, J., Meijer, C. J., Berkhof, J., Yi, Y., van Wieringen, W. N., Braakhuis, B. J., Meijer, G. A., Ylstra, B., Snijders, P. J., and Steenbergen, R. D. (2008) Integrated genomic and transcriptional profiling identifies chromosomal loci with altered gene expression in cervical cancer. Genes Chromosomes Cancer 47, 890-905
15. Barkett, M., and Gilmore, T. D. (1999) Control of apoptosis by Rel/NF-κB transcription factors. Oncogene 18, 6910-6924
16. Hayden, M. S., and Ghosh, S. (2004) Signaling to NF-κB. Genes Dev. 18, 2195-2224
17. Chen, G., and Goeddel, D. V. (2002) TNF-R1 signaling: a beautiful pathway. Science 296, 1634-1635 (Pubitemid 34579145)
18. Karin, M. (2006) Nuclear factor-κB in cancer development and progression. Nature 441, 431-436
19. Nair, A., Venkatraman, M., Maliekal, T. T., Nair, B., and Karunagaran, D. (2003) NF-κB is constitutively activated in high-grade squamous intraepithelial lesions and squamous cell carcinomas of the human uterine cervix. Oncogene 22, 50-58 (Pubitemid 36152883)
20. Chen, C., Peng, J., Xia, H., Wu, Q., Zeng, L., Xu, H., Tang, H., Zhang, Z., Zhu, X., Pang, D., and Li, Y. (2010) Quantum-dot-based immunofluorescent imaging of HER2 and ER provides new insights into breast cancer heterogeneity. Nanotechnology 21, 095101
21. Sherr, C. J. (1996) Cancer cell cycles. Science 274, 1672-1677
22. Tjiong, M. Y., van der Vange, N., ter Schegget, J. S., Burger, M. P., ten Kate, F. W., and Out, T. A. (2001) Cytokines in cervicovaginal washing fluid from patients with cervical neoplasia. Cytokine 14, 357-360 (Pubitemid 32730478)
23. Vieira, K. B., Goldstein, D. J., and Villa, L. L. (1996) Tumor necrosis factor α interferes with the cell cycle of normal and papillomavirus- immortalized human keratinocytes. Cancer Res. 56, 2452-2457 (Pubitemid 26154098)
24. Häcker, H., and Karin, M. (2006) Regulation and function of IKK and IKK-related kinases. Sci. STKE 2006, re13
25. Ran, R., Lu, A., Zhang, L., Tang, Y., Zhu, H., Xu, H., Feng, Y., Han, C., Zhou, G., Rigby, A. C., and Sharp, F. R. (2004) Hsp70 promotes TNF-mediated apoptosis by binding IKKγ and impairing NF-κB survival signaling. Genes Dev. 18, 1466-1481 (Pubitemid 38780632)
26. Looman, C., Abrink, M., Mark, C., and Hellman, L. (2002) KRAB zinc finger proteins. An analysis of the molecular mechanisms governing their increase in numbers and complexity during evolution. Mol. Biol. Evol. 19, 2118-2130 (Pubitemid 35440448)
27. Faustino, N. A., and Cooper, T. A. (2003) Pre-mRNA splicing and human disease. Genes Dev. 17, 419-437 (Pubitemid 36258756)
28. Brinkman, B. M. (2004) Splice variants as cancer biomarkers. Clin. Biochem. 37, 584-594
29. Woerner, S. M., Givehchian, M., Dürst, M., Schneider, A., Costa, S., Melsheimer, P., Lacroix, J., Zöller, M., and Doeberitz, M. K. (1995) Expression of CD44 splice variants in normal, dysplastic, and neoplastic cervical epithelium. Clin. Cancer Res. 1, 1125-1132
30. Rosenberger, S., De-Castro Arce, J., Langbein, L., Steenbergen, R. D., and Rösl, F. (2010) Alternative splicing of human papillomavirus type-16 E6/E6*early mRNA is coupled to EGF signaling via Erk1/2 activation. Proc. Natl. Acad. Sci. U.S.A. 107, 7006-7011
31. Wang, S. C., and Hung, M. C. (2005) Cytoplasmic/nuclear shuttling and tumor progression. Ann. N.Y. Acad. Sci. 1059, 11-15
32. Sun, Y., Gou, D. M., Liu, H., Peng, X., and Li, W. X. (2003) The KRAB domain of zinc finger gene ZNF268: a potential transcriptional repressor. IUBMB Life 55, 127-131 (Pubitemid 36702656)
33. Branca, M., Giorgi, C., Ciotti, M., Santini, D., Di Bonito, L., Costa, S., Benedetto, A., Bonifacio, D., Di Bonito, P., Paba, P., Accardi, L., Mariani, L., Ruutu, M., Syrjänen, S., Favalli, C., and Syrjänen, K. (2006) Up-regulation of nuclear factor-κB (NF-κB) is related to the grade of cervical intraepithelial neoplasia, but is not an independent predictor of high-risk human papillomavirus or disease outcome in cervical cancer. Diagn. Cytopathol. 34, 555-563 (Pubitemid 44157177)
34. Van Waes, C. (2007) Nuclear factor-κB in development, prevention, and therapy of cancer. Clin. Cancer Res. 13, 1076-1082
35. Guttridge, D. C., Albanese, C., Reuther, J. Y., Pestell, R. G., and Baldwin, A. S., Jr. (1999) NF-κB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol. Cell. Biol. 19, 5785-5799 (Pubitemid 29339933)
36. Baldin, V., Lukas, J., Marcote, M. J., Pagano, M., and Draetta, G. (1993) Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev. 7, 812-821 (Pubitemid 23163585)
37. Weinberg, R. A. (1995) The retinoblastoma protein and cell cycle control. Cell 81, 323-330
38. Lee, H. H., Dadgostar, H., Cheng, Q., Shu, J., and Cheng, G. (1999) NF-κB-mediated up-regulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes. Proc. Natl. Acad. Sci. U.S.A. 96, 9136-9141 (Pubitemid 29374720)
39. Philip, M., Rowley, D. A., and Schreiber, H. (2004) Inflammation as a tumor promoter in cancer induction. Semin. Cancer Biol. 14, 433-439 (Pubitemid 39360991)
40. Suganuma, M., Okabe, S., Marino, M. W., Sakai, A., Sueoka, E., and Fujiki, H. (1999) Essential role of tumor necrosis factor α (TNF-α) in tumor promotion as revealed by TNF-α-deficient mice. Cancer Res. 59, 4516-4518 (Pubitemid 29428949)
41. Moore, R. J., Owens, D. M., Stamp, G., Arnott, C., Burke, F., East, N., Holdsworth, H., Turner, L., Rollins, B., Pasparakis, M., Kollias, G., and Balkwill, F. (1999) Mice deficient in tumor necrosis factor-α are resistant to skin carcinogenesis. Nat. Med. 5, 828-831 (Pubitemid 29318619)